Application Nr Approved Date Route Status External Links
NDA022000 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lialda Is Indicated For The: Induction And Maintenance Of Remission In Adult Patients With Mildly To Moderately Active Ulcerative Colitis. Treatment Of Mildly To Moderately Active Ulcerative Colitis In Pediatric Patients Weighing At Least 24 Kg. Lialda Is An Aminosalicylate Indicated For The: Induction And Maintenance Of Remission In Adult Patients With Mildly To Moderately Active Ulcerative Colitis. ( 1 ) Treatment Of Mildly To Moderately Active Ulcerative Colitis In Pediatric Patients Weighing At Least 24 Kg. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mesalamine MESALAMINE ZINC1688

Comments